Connection

Roberto Cauda to Humans

This is a "connection" page, showing publications Roberto Cauda has written about Humans.
Connection Strength

0.119
  1. Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients. Future Microbiol. 2020 10; 15:1523-1526.
    View in: PubMed
    Score: 0.007
  2. Psychopathological profile in COVID-19 patients including healthcare workers: the implications. Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11964-11970.
    View in: PubMed
    Score: 0.007
  3. A call to research: the relationship between SARS-2-CoV, ACE 2 and antihypertensives. Pathog Glob Health. 2020 05 18; 114(4):165-167.
    View in: PubMed
    Score: 0.007
  4. A pilot experience of common European infectious diseases curriculum for medical students: the IDEAL summer school. Future Microbiol. 2019 03; 14:369-372.
    View in: PubMed
    Score: 0.007
  5. IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines. Clin Infect Dis. 2018 05 17; 66(11):1815-1816.
    View in: PubMed
    Score: 0.006
  6. Antibiotic stewardship from toolkit to local implementation: the 'gutta cavat lapidem' strategy. Future Microbiol. 2017 09; 12:935-938.
    View in: PubMed
    Score: 0.006
  7. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother. 2008 Nov; 62(5):1130-7.
    View in: PubMed
    Score: 0.003
  8. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003 Nov; 3(11):722-7.
    View in: PubMed
    Score: 0.002
  9. SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate? J Med Virol. 2021 Dec; 93(12):6551-6556.
    View in: PubMed
    Score: 0.002
  10. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
    View in: PubMed
    Score: 0.002
  11. Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials. Pathog Glob Health. 2021 Oct-Dec; 115(7-8):456-466.
    View in: PubMed
    Score: 0.002
  12. SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy. Commun Biol. 2021 04 21; 4(1):489.
    View in: PubMed
    Score: 0.002
  13. Psychological distress during the initial stage of the COVID-19 pandemic in an Italian population living with HIV: an online survey. Infez Med. 2021 Mar 01; 29(1):54-64.
    View in: PubMed
    Score: 0.002
  14. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.002
  15. Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. AIDS. 2000 Dec 22; 14(18):2948-9.
    View in: PubMed
    Score: 0.002
  16. Liability of Health Care Professionals and Institutions During COVID-19 Pandemic in Italy: Symposium Proceedings and Position Statement. J Patient Saf. 2020 12; 16(4):e299-e302.
    View in: PubMed
    Score: 0.002
  17. People Living with HIV in the COVID-19 Era: A Case Report. AIDS Res Hum Retroviruses. 2021 04; 37(4):253-254.
    View in: PubMed
    Score: 0.002
  18. The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic. HIV Med. 2021 01; 22(1):e3-e4.
    View in: PubMed
    Score: 0.002
  19. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
    View in: PubMed
    Score: 0.002
  20. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab. Infection. 2020 Oct; 48(5):767-771.
    View in: PubMed
    Score: 0.002
  21. Off-label use of tocilizumab in patients with SARS-CoV-2 infection. J Med Virol. 2020 10; 92(10):1787-1788.
    View in: PubMed
    Score: 0.002
  22. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission. J Med Virol. 2020 10; 92(10):2232-2237.
    View in: PubMed
    Score: 0.002
  23. Ethical Criteria for the Admission and Management of Patients in the ICU Under Conditions of Limited Medical Resources: A Shared International Proposal in View of the COVID-19 Pandemic. Front Public Health. 2020; 8:284.
    View in: PubMed
    Score: 0.002
  24. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity? Infect Dis (Lond). 2020 08; 52(8):585-589.
    View in: PubMed
    Score: 0.002
  25. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive. J Infect. 2021 01; 82(1):159-198.
    View in: PubMed
    Score: 0.002
  26. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Int J Antimicrob Agents. 2020 Aug; 56(2):106017.
    View in: PubMed
    Score: 0.002
  27. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy. J Infect. 2020 07; 81(1):e24-e27.
    View in: PubMed
    Score: 0.002
  28. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum ß-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul; 54(1):49-54.
    View in: PubMed
    Score: 0.002
  29. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach. Eur Rev Med Pharmacol Sci. 2019 Apr; 23(7):2978-2985.
    View in: PubMed
    Score: 0.002
  30. Liver fibrosis is associated with cognitive impairment in people living with HIV. Infection. 2019 Aug; 47(4):589-593.
    View in: PubMed
    Score: 0.002
  31. Use of procalcitonin as a tool for antibiotic stewardship. Future Microbiol. 2019 01; 14:77-79.
    View in: PubMed
    Score: 0.002
  32. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. J Antimicrob Chemother. 2018 07 01; 73(7):1955-1964.
    View in: PubMed
    Score: 0.002
  33. Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy. J Antimicrob Chemother. 2018 07 01; 73(7):1949-1954.
    View in: PubMed
    Score: 0.002
  34. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clin Microbiol Infect. 2019 Apr; 25(4):474-480.
    View in: PubMed
    Score: 0.002
  35. Systematic clinical management of patients with candidemia improves survival. J Infect. 2018 08; 77(2):145-150.
    View in: PubMed
    Score: 0.002
  36. Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections. Eur Rev Med Pharmacol Sci. 2018 05; 22(10):3130-3137.
    View in: PubMed
    Score: 0.002
  37. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. Eur Spine J. 2018 06; 27(Suppl 2):229-236.
    View in: PubMed
    Score: 0.002
  38. 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. Antivir Ther. 2018; 23(2):139-148.
    View in: PubMed
    Score: 0.001
  39. Osteoarticular bacterial infections are rare in HIV-infected patients. 14 cases found among 4,023 HIV-infected patients. Acta Orthop Scand. 1997 Dec; 68(6):554-8.
    View in: PubMed
    Score: 0.001
  40. A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018 Jan; 37(1):167-173.
    View in: PubMed
    Score: 0.001
  41. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
    View in: PubMed
    Score: 0.001
  42. Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin. Intern Emerg Med. 2017 Oct; 12(7):1059-1067.
    View in: PubMed
    Score: 0.001
  43. Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial. J Antimicrob Chemother. 2017 07 01; 72(7):2055-2059.
    View in: PubMed
    Score: 0.001
  44. Antibodies against a ß-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients. Sci Rep. 2017 06 02; 7(1):2722.
    View in: PubMed
    Score: 0.001
  45. International infectious diseases teaching to undergraduate medical students: A successful European collaborative experience. Med Teach. 2017 Sep; 39(9):981-986.
    View in: PubMed
    Score: 0.001
  46. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries??. Int J Clin Pharmacol Ther. 2017 May; 55(5):381-393.
    View in: PubMed
    Score: 0.001
  47. Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). J Antimicrob Chemother. 2017 04 01; 72(4):1163-1171.
    View in: PubMed
    Score: 0.001
  48. New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years. Eur Spine J. 2017 10; 26(Suppl 4):479-488.
    View in: PubMed
    Score: 0.001
  49. Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection. 2017 Apr; 45(2):209-213.
    View in: PubMed
    Score: 0.001
  50. Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality. PLoS One. 2017; 12(2):e0170236.
    View in: PubMed
    Score: 0.001
  51. Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients. AIDS. 2017 01 28; 31(3):457-459.
    View in: PubMed
    Score: 0.001
  52. Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients. J Chemother. 2017 Oct; 29(5):299-307.
    View in: PubMed
    Score: 0.001
  53. Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1. Curr HIV Res. 2008 Jun; 6(4):306-17.
    View in: PubMed
    Score: 0.001
  54. Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. Respir Med. 1996 Oct; 90(9):531-7.
    View in: PubMed
    Score: 0.000
  55. [Methionine Se 75 in hepatic scintigraphic diagnosis]. Arch Maragliano Patol Clin. 1976; 32:19-36.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.